Astrazeneca Pharma India Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Astrazeneca Pharma India Ltd with 125 companies shown from the same industry classification, including Marksans Pharma Ltd, Concord Biotech Ltd, Jubilant Pharmova Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharma India Ltd | 14,774 Cr. | 5,909 | 9,850/5,882 | 85.2 | 349 | 0.61 % | 29.3 % | 23.3 % | 2.00 |
| Marksans Pharma Ltd | 15,048 Cr. | 332 | 351/155 | 29.1 | 66.7 | 0.27 % | 18.8 % | 15.2 % | 1.00 |
| Concord Biotech Ltd | 14,175 Cr. | 1,356 | 1,648/987 | 49.8 | 193 | 0.56 % | 17.4 % | 12.6 % | 1.00 |
| Jubilant Pharmova Ltd | 15,616 Cr. | 982 | 1,185/784 | 40.2 | 445 | 0.51 % | 8.99 % | 6.53 % | 1.00 |
| Natco Pharma Ltd | 16,106 Cr. | 822 | 1,217/786 | 14.1 | 470 | 0.61 % | 17.4 % | 17.1 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,344 Cr. | 831 | 998/635 | 21.9 | 289 | 1.44 % | 12.6 % | 13.4 % | 2.00 |
| ERIS Lifesciences Ltd | 16,490 Cr. | 1,189 | 1,740/1,163 | 25.2 | 282 | 0.61 % | 14.1 % | 18.7 % | 1.00 |
| Cohance Lifesciences Ltd | 17,089 Cr. | 447 | 918/267 | 159 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Pfizer Ltd | 17,595 Cr. | 3,842 | 5,578/3,792 | 22.9 | 919 | 1.95 % | 24.1 % | 18.0 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,055 Cr. | 532 | 693/325 | 42.8 | 78.4 | 0.23 % | 26.1 % | 19.4 % | 2.00 |
| Caplin Point Laboratories Ltd | 19,790 Cr. | 2,604 | 2,991/1,500 | 29.7 | 443 | 0.31 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 20,177 Cr. | 1,031 | 1,096/260 | 71.0 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Procter & Gamble Health Ltd | 8,791 Cr. | 5,300 | 6,975/4,700 | 26.4 | 316 | 2.92 % | 83.9 % | 61.9 % | 10.0 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Suven Life Sciences Ltd | 8,649 Cr. | 306 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Aarti Pharmalabs Ltd | 8,603 Cr. | 947 | 1,002/584 | 40.0 | 234 | 0.37 % | 10.7 % | 8.59 % | 5.00 |
| Morepen Laboratories Ltd | 7,414 Cr. | 135 | 138/33.0 | 63.2 | 22.8 | 0.15 % | 8.05 % | 5.33 % | 2.00 |
| Entero Healthcare Solutions Ltd | 7,378 Cr. | 1,697 | 1,920/944 | 57.2 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Granules India Ltd | 22,319 Cr. | 817 | 924/520 | 34.3 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Bliss GVS Pharma Ltd | 7,063 Cr. | 665 | 745/118 | 51.3 | 113 | 0.23 % | 16.9 % | 11.8 % | 1.00 |
| Sanofi India Ltd | 6,978 Cr. | 3,024 | 4,898/3,000 | 20.4 | 359 | 2.48 % | 57.5 % | 43.0 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 6,036 Cr. | 206 | 219/67.1 | 34.2 | 61.3 | 0.49 % | 11.3 % | 8.42 % | 2.00 |
| Orchid Pharma Ltd | 5,775 Cr. | 966 | 1,144/471 | 320 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,400 Cr. | 331 | 476/313 | 17.5 | 153 | 1.51 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 4,855 Cr. | 374 | 479/225 | 99.7 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 4,780 Cr. | 2,896 | 3,130/1,731 | 41.0 | 366 | 0.83 % | 25.7 % | 19.3 % | 8.00 |
| Zota Health Care Ltd | 4,493 Cr. | 1,297 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 4,472 Cr. | 478 | 494/262 | 49.4 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,211 Cr. | 420 | 468/268 | 57.3 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Acutaas Chemicals Ltd | 25,572 Cr. | 3,122 | 3,740/1,374 | 66.2 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Aarti Drugs Limited | 3,778 Cr. | 415 | 534/319 | 21.8 | 154 | 0.48 % | 11.7 % | 12.7 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 3,773 Cr. | 3,644 | 3,949/829 | 46.2 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Unichem Laboratories Ltd | 3,739 Cr. | 531 | 687/278 | 30.6 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Ind-Swift Laboratories Ltd | 3,354 Cr. | 386 | 425/87.0 | 51.5 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,280 Cr. | 677 | 774/422 | 768 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 3,049 Cr. | 272 | 420/252 | 19.3 | 146 | 1.96 % | 14.0 % | 10.2 % | 2.00 |
| Hikal Ltd | 2,644 Cr. | 214 | 261/146 | 62.4 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Venus Remedies Ltd | 2,393 Cr. | 1,778 | 2,044/432 | 20.6 | 497 | 0.56 % | 20.7 % | 15.6 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,369 Cr. | 152 | 307/128 | 131 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Indoco Remedies Ltd | 2,278 Cr. | 247 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Fredun Pharmaceuticals Ltd | 2,258 Cr. | 1,363 | 1,600/454 | 50.8 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Beta Drugs Ltd | 2,222 Cr. | 2,004 | 2,808/990 | 48.7 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Syncom Formulations (India) Ltd | 2,174 Cr. | 23.1 | 27.5/10.2 | 25.6 | 4.39 | 0.43 % | 24.8 % | 17.6 % | 1.00 |
| Panacea Biotec Ltd | 2,152 Cr. | 350 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Hester Biosciences Ltd | 1,780 Cr. | 2,106 | 2,684/1,239 | 33.5 | 423 | 0.52 % | 15.2 % | 15.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,646 Cr. | 557 | 580/249 | 30.1 | 138 | 0.67 % | 20.6 % | 16.4 % | 5.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,515 Cr. | 229 | 265/155 | 32.2 | 41.2 | 1.74 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,496 Cr. | 518 | 760/476 | 24.0 | 128 | 0.95 % | 24.8 % | 18.4 % | 1.00 |
| Neuland Laboratories Ltd | 28,077 Cr. | 21,875 | 24,235/11,500 | 56.4 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| TTK Healthcare Ltd | 1,422 Cr. | 1,007 | 1,250/735 | 18.6 | 789 | 0.99 % | 8.04 % | 6.30 % | 10.0 |
| Kopran Ltd | 1,298 Cr. | 269 | 296/107 | 51.9 | 110 | 1.12 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,136 Cr. | 567 | 770/440 | 11.8 | 378 | 0.32 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,031 Cr. | 113 | 147/65.0 | 43.3 | 0.44 % | 2.74 % | 0.41 % | 1.00 | |
| Bafna Pharmaceuticals Ltd | 899 Cr. | 386 | 393/94.8 | 115 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Anuh Pharma Ltd | 833 Cr. | 84.2 | 99.5/66.7 | 18.9 | 35.1 | 1.78 % | 14.9 % | 10.7 % | 5.00 |
| Kilitch Drugs (India) Ltd | 826 Cr. | 234 | 248/117 | 27.5 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Wanbury Ltd | 663 Cr. | 190 | 360/162 | 15.4 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Albert David Ltd | 481 Cr. | 836 | 932/580 | 21.3 | 686 | 0.60 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 334 Cr. | 104 | 108/50.3 | 80.2 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| Lyka Labs Ltd | 277 Cr. | 77.5 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| BDH Industries Ltd | 273 Cr. | 474 | 610/340 | 23.3 | 134 | 1.06 % | 20.5 % | 14.8 % | 10.0 |
| Gennex Laboratories Ltd | 241 Cr. | 9.90 | 17.2/7.05 | 12.8 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Everest Organics Ltd | 235 Cr. | 236 | 536/197 | 44.8 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 202 Cr. | 10.5 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Coral Laboratories Ltd | 201 Cr. | 562 | 679/360 | 10.6 | 585 | 0.36 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 170 Cr. | 107 | 125/59.7 | 23.6 | 51.6 | 1.12 % | 9.69 % | 7.87 % | 10.0 |
| Brooks Laboratories Ltd | 159 Cr. | 54.2 | 138/36.3 | 12.0 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Par Drugs & Chemicals Ltd | 155 Cr. | 126 | 180/78.0 | 10.7 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Auro Laboratories Ltd | 144 Cr. | 231 | 317/159 | 30.0 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Achyut Healthcare Ltd | 139 Cr. | 5.74 | 10.0/4.70 | 433 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 135 Cr. | 64.0 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 133 Cr. | 9.09 | 14.3/1.96 | 44.4 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Godavari Drugs Ltd | 127 Cr. | 117 | 135/69.7 | 32.7 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Alpa Laboratories Ltd | 123 Cr. | 59.0 | 99.8/46.0 | 28.1 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Vaishali Pharma Ltd | 108 Cr. | 8.28 | 11.9/4.75 | 25.5 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 106 Cr. | 30.2 | 60.0/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Concord Drugs Ltd | 101 Cr. | 76.9 | 92.5/61.0 | 49.7 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 93.3 Cr. | 67.3 | 97.4/56.1 | 11.7 | 66.0 | 3.72 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 77.0 Cr. | 15.4 | 26.0/13.0 | 21.2 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 62.4 Cr. | 25.0 | 25.0/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| ANG Lifesciences India Ltd | 51.4 Cr. | 39.4 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Vivimed Labs Ltd | 50.6 Cr. | 5.99 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 47.7 Cr. | 29.6 | 46.8/25.6 | 99.4 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Mangalam Drugs and Organics Ltd | 46.4 Cr. | 29.2 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Bacil Pharma Ltd | 39.1 Cr. | 27.3 | 61.8/10.6 | 60.2 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.53/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Chandra Bhagat Pharma Ltd | 35.4 Cr. | 46.9 | 53.0/29.7 | 11.6 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Bharat Immunological & Biological Corporation Ltd | 32.5 Cr. | 7.53 | 22.6/7.42 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Gujarat Terce Laboratories Ltd | 27.1 Cr. | 34.8 | 59.8/29.0 | 12.2 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Colinz Laboratories Ltd | 18.4 Cr. | 73.0 | 87.9/36.1 | 36.8 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 18.0 Cr. | 32.8 | 144/28.4 | 14.6 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Beryl Drugs Ltd | 12.6 Cr. | 24.8 | 27.6/15.9 | 20.3 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.4 Cr. | 75.9 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Dipna Pharmachem Ltd | 11.2 Cr. | 4.28 | 25.0/3.90 | 4.28 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 17.1/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 7.35 Cr. | 24.5 | 24.7/17.7 | 8.65 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 5.73 Cr. | 5.67 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.22 Cr. | 0.79 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.78 Cr. | 1.52 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Wockhardt Ltd | 33,488 Cr. | 2,064 | 2,422/1,087 | 84.0 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 43,546 Cr. | 3,486 | 3,797/2,380 | 38.4 | 362 | 0.92 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 46,239 Cr. | 2,733 | 3,121/2,088 | 43.9 | 134 | 2.09 % | 61.4 % | 45.6 % | 10.0 |
| Gland Pharma Ltd | 48,056 Cr. | 2,912 | 3,042/1,574 | 34.0 | 656 | 0.69 % | 17.4 % | 12.8 % | 1.00 |
| Ipca Laboratories Ltd | 49,578 Cr. | 1,951 | 2,039/1,252 | 36.1 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Abbott India Ltd | 55,776 Cr. | 26,240 | 30,655/25,135 | 34.5 | 2,247 | 2.00 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 60,234 Cr. | 370 | 447/338 | 82.8 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Alkem Laboratories Ltd | 61,847 Cr. | 5,192 | 5,934/5,051 | 27.2 | 1,156 | 1.02 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Life Sciences Ltd | 64,624 Cr. | 2,295 | 2,538/1,793 | 20.7 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 64,624 Cr. | 2,295 | 2,538/1,793 | 20.7 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 92,061 Cr. | 2,011 | 2,530/1,900 | 15.5 | 491 | 0.90 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 96,474 Cr. | 1,675 | 1,740/1,066 | 25.5 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,922 Cr. | 1,203 | 1,415/1,080 | 31.3 | 454 | 0.67 % | 13.0 % | 11.2 % | 1.00 |
| Mankind Pharma Ltd | 1,02,718 Cr. | 2,479 | 2,642/1,910 | 45.4 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Laurus Labs Ltd | 1,06,249 Cr. | 1,971 | 2,055/843 | 122 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Cipla Ltd | 1,07,663 Cr. | 1,336 | 1,673/1,166 | 30.1 | 426 | 0.97 % | 15.5 % | 11.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,81,715 Cr. | 4,772 | 5,250/3,480 | 81.4 | 248 | 0.80 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,414.60 Cr | 1,241.25 | 54.24 | 211.24 | 0.39% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Astrazeneca Pharma India Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Astrazeneca Pharma India Ltd analysis · Explore all Pharmaceuticals stocks